drugset / Trial / NCT02133534
The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if patients with chronic kidney disease have endothelial cells that don't function properly, which is thought to be a marker for cardiovascular risk. Endothelial cells line the heart and blood vessels. The investigators will treat your high cholesterol with a cholesterol-lowering drug (atorvastatin, or Lipitor). They will determine if this cholesterol lowering drug improves subjects' cholesterol as well as the function of endothelial cells.
Timeline
- Start
- 2008-02
- Primary completion
- 2009-05
- Completion
- 2009-05
Outcome
Outcome not reported
Stopped (Enrollment): “failure to enroll”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 10 mg | — |